Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 1998;80:211-212; doi:10.1136/hrt.80.3.211
Copyright © 1998 BMJ Publishing Group Ltd & British Cardiovascular Society

Heart 1998;80:211-212 ( September )

Editorial

Transfusion associated graft versus host disease and its prevention

The first 150 words of the full text of this article appear below.

Transfusion associated graft versus host disease (TA-GVHD) is a rare but lethal complication of transfusion,1 generally associated with immunosuppressed patients. As described in the case report in this issue,2 however, the condition can occur in fully immunocompetent individuals, with the onset of symptoms usually 1-2 weeks after transfusion. Patients experience the classic features of GVHD: skin rash, diarrhoea, fever, and hepatitic liver damage with or without jaundice. What makes TA-GVHD so devastating is the involvement of the bone marrow, with severe hypoplasia leading to profound pancytopenia. The disease then follows a downhill course with death, usually caused by infection, in more than 90% of cases. Once established, the condition is not amenable to treatment. Fortunately, it appears to be entirely preventable if cellular blood components (red cells and platelets) are gamma  irradiated before transfusion. This is currently performed only for patients deemed at particular risk of TA-GVHD; however, recognition and reporting . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Juneja, V., Keegan, P., Gootenberg, J. E., Rothmann, M. D., Shen, Y. L., Lee, K. Y., Weiss, K. D., Pazdur, R. (2008). Continuing Reassessment of the Risks of Erythropoiesis-Stimulating Agents in Patients with Cancer. Clin. Cancer Res. 14: 3242-3247 [Abstract] [Full Text]  
  • GHREW, M H, RINGROSE, T, YOUNG, D, PETO, T (1999). Transfusion associated graft versus host disease. Heart 82: 255-256 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.